Primeros pobladores de Australia, la explosión cósmica más brillante,motores eléctricos para aviones
Noticias de la actualidad científica y tecnológica del 19 de junio de 2023. …
Uncategorized
Medtronic secures Medicare coverage for MiniMed 780G insulin pump
Medtronic has begun processing orders and will start shipping devices over the next few weeks.
Medtronic secures Medicare coverage for MiniMed 780G insulin pump Read More »
HCA reports data security incident affecting estimated 11M patients
The health system said data like name and contact details, though not clinical information, was stolen from an external storage location and posted online.
HCA reports data security incident affecting estimated 11M patients Read More »
Judge throws out class action lawsuit against Teladoc
A New York judge ruled that Teladoc had detailed risks of its $18 billion Livongo acquisition and that, while the company may have been optimistic regarding its operations, it did not falsify facts or statements.
Judge throws out class action lawsuit against Teladoc Read More »
CMS to return $9B to 340B hospitals under new plan
Hospital groups said the proposed rule is an important step toward restitution for years of 340B underpayments, but they criticized regulators for proposed rate decreases and a lack of additional interest payments.
CMS to return $9B to 340B hospitals under new plan Read More »
Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®)
Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA ® ) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN).
Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics for Use in Pediatric Patients, and for Use Against Biothreat Pathogens
Melinta Therapeutics, LLC announced today a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to advance two antibiotics currently FDA-approved for adults, BAXDELA® (delafloxacin) and VABOMERE® (meropenem and vaborbactam), for use in pediatrics.
ReCode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs
ReCode Therapeutics announced today the appointment of Erica Jefferson as senior vice president of corporate affairs.
Race executes global license agreement with City of Hope to access FTO IP
Race executes worldwide license agreement with City of Hope, one of the largest cancer research and treatment organisations in the United States.
Race executes global license agreement with City of Hope to access FTO IP Read More »
NovaBay Pharmaceuticals Announces Exclusive Amazon Prime Day 2023 Promotions on All Avenova-Branded Products
NovaBay® Pharmaceuticals, Inc., a company developing and commercializing high-quality eyecare, skincare and wound care products, announces special pricing on Avenova®-branded products to Amazon prime members during Prime Day 2023, being held July 11-12.